Bladder cancer is the most common cancer of the urinary system — and one of the most important cancers to understand, because it has a highly recognisable early warning sign that, if acted on promptly, gives patients an excellent chance of successful treatment.
That warning sign is blood in the urine. Painless, visible blood in urine — even a single episode — is the most common presenting symptom of bladder cancer, occurring in over 80% of cases. Yet many people who experience it wait, rationalise, or assume it was a one-off before seeking medical attention. That delay can be the difference between a straightforward, curative procedure and a far more complex treatment journey.
Understanding Bladder Cancer
The bladder is a hollow, muscular organ that stores urine before it is expelled from the body. Bladder cancer occurs when cells lining the inside of the bladder — called urothelial cells — begin to grow abnormally. The most common type, urothelial carcinoma (formerly transitional cell carcinoma), accounts for over 90% of all bladder cancers.
Bladder cancers are broadly classified by how deeply they have grown into the bladder wall:
- Non-muscle invasive bladder cancer (NMIBC): Confined to the inner lining. Highly treatable but with a significant tendency to recur.
- Muscle-invasive bladder cancer (MIBC): Has grown into the muscular bladder wall. Requires more aggressive treatment but is still potentially curable.
- Metastatic bladder cancer: Has spread beyond the bladder to lymph nodes or other organs. Requires systemic treatment.
Risk Factors for Bladder Cancer
Understanding who is at higher risk helps identify who should be particularly vigilant about symptoms and screening:
- Smoking: The single most significant risk factor. Smokers are 4-7 times more likely to develop bladder cancer than non-smokers. Carcinogens from tobacco are filtered by the kidneys and concentrated in the urine — directly exposing the bladder lining for extended periods.
- Occupational chemical exposure: Workers in dye, rubber, leather, printing, and chemical industries have higher bladder cancer rates due to aromatic amine exposure.
- Age: Most bladder cancers are diagnosed in adults above 55.
- Gender: Men are approximately three times more likely to develop bladder cancer than women — though women tend to be diagnosed at later stages.
- Recurrent UTIs and chronic bladder irritation: Long-standing bladder inflammation is associated with certain bladder cancer subtypes.
- Previous pelvic radiation: Prior radiation therapy for other cancers increases risk.
Symptoms of Bladder Cancer
Recognising the symptoms of bladder cancer early is life-saving. The most important signs include:
- Haematuria (blood in urine): Painless, visible blood in urine is the cardinal symptom. It may appear intermittently — even resolving completely between episodes — which can falsely reassure patients that it has gone away.
- Frequent or urgent urination without obvious cause.
- Pain or burning during urination.
- Pelvic or lower back pain in more advanced cases.
- Unexplained weight loss, fatigue, or bone pain in metastatic disease.
The critical message: a single episode of painless blood in urine demands full urological investigation — immediately. Not next month. Not after it happens again.
How Is Bladder Cancer Diagnosed?
Diagnosis involves a combination of urine tests, imaging, and direct endoscopic examination:
- Urine cytology: Microscopic examination of shed cells in the urine for malignant cells.
- CT Urogram (CTU): Detailed imaging of the entire urinary tract to identify tumours, their location, and extent.
- Flexible cystoscopy: The gold standard — a thin camera passed through the urethra allows direct visual inspection of the bladder interior. Any suspicious lesion is biopsied.
- TURBT (Transurethral Resection of Bladder Tumour): Both a diagnostic and therapeutic procedure — the tumour is resected endoscopically under anaesthesia, providing definitive histopathological diagnosis and staging.
Treatment Options for Bladder Cancer
TURBT — For Non-Muscle Invasive Disease
Endoscopic resection of the tumour through the urethra — no external incisions. Followed by intravesical instillation of BCG (immunotherapy) or chemotherapy agents directly into the bladder to reduce recurrence risk. Regular surveillance cystoscopies are essential as NMIBC has a high recurrence rate.
Radical Cystectomy — For Muscle-Invasive Disease
Surgical removal of the bladder, surrounding tissues, and lymph nodes for muscle-invasive cancer. Robotic-assisted radical cystectomy minimises blood loss, reduces complications, and speeds recovery. A urinary diversion is created to allow urine to exit the body, the form of which is discussed extensively with each patient.
Chemotherapy and Immunotherapy
Systemic chemotherapy before surgery (neoadjuvant) improves long-term outcomes in muscle-invasive disease. Checkpoint inhibitor immunotherapy has shown significant benefit in advanced and metastatic bladder cancer.
Surveillance: Why Follow-Up Is Non-Negotiable
Bladder cancer has the highest recurrence rate of any cancer — making lifelong surveillance with periodic cystoscopy a non-negotiable part of management for all patients treated for NMIBC. Early detection of recurrence allows prompt treatment before the cancer progresses to a more invasive stage.
Dr. Prarthan Joshi at Zydus Hospitals, Ahmedabad, provides comprehensive bladder cancer evaluation, TURBT, and ongoing surveillance — helping patients navigate their diagnosis with expertise and confidence. For specialised Bladder Cancer Treatment in Ahmedabad, do not delay. Early evaluation is your greatest advantage.